image
Technology - Information Technology Services - NYSE - GB
$ 4.325
-0.686 %
$ 2.95 B
Market Cap
-4.47
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CLVT stock under the worst case scenario is HIDDEN Compared to the current market price of 4.33 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CLVT stock under the base case scenario is HIDDEN Compared to the current market price of 4.33 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one CLVT stock under the best case scenario is HIDDEN Compared to the current market price of 4.33 USD, Clarivate Plc is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLVT

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
2.56 B REVENUE
-2.74%
-276 M OPERATING INCOME
62.49%
-637 M NET INCOME
30.13%
647 M OPERATING CASH FLOW
-13.11%
-237 M INVESTING CASH FLOW
0.29%
-470 M FINANCING CASH FLOW
5.32%
594 M REVENUE
-10.45%
-20.8 M OPERATING INCOME
66.61%
-104 M NET INCOME
45.83%
171 M OPERATING CASH FLOW
21.16%
-60.9 M INVESTING CASH FLOW
-284.58%
-56.6 M FINANCING CASH FLOW
76.38%
Balance Sheet Clarivate Plc
image
Current Assets 1.24 B
Cash & Short-Term Investments 295 M
Receivables 798 M
Other Current Assets 151 M
Non-Current Assets 10.2 B
Long-Term Investments 0
PP&E 107 M
Other Non-Current Assets 10.1 B
6.95 %88.24 %Total Assets$11.5b
Current Liabilities 1.43 B
Accounts Payable 124 M
Short-Term Debt 41.2 M
Other Current Liabilities 1.27 B
Non-Current Liabilities 4.92 B
Long-Term Debt 4.57 B
Other Non-Current Liabilities 346 M
19.96 %71.98 %5.44 %Total Liabilities$6.4b
EFFICIENCY
Earnings Waterfall Clarivate Plc
image
Revenue 2.56 B
Cost Of Revenue 869 M
Gross Profit 1.69 B
Operating Expenses 1.96 B
Operating Income -276 M
Other Expenses 361 M
Net Income -637 M
3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)3b(869m)2b(2b)(276m)(361m)(637m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
66.00% GROSS MARGIN
66.00%
-10.78% OPERATING MARGIN
-10.78%
-24.90% NET MARGIN
-24.90%
-12.39% ROE
-12.39%
-5.54% ROA
-5.54%
-3.14% ROIC
-3.14%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Clarivate Plc
image
600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -637 M
Depreciation & Amortization 727 M
Capital Expenditures -289 M
Stock-Based Compensation 59.9 M
Change in Working Capital -24.9 M
Others 398 M
Free Cash Flow 358 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Clarivate Plc
image
Wall Street analysts predict an average 1-year price target for CLVT of $14.3 , with forecasts ranging from a low of $11 to a high of $20 .
CLVT Lowest Price Target Wall Street Target
11 USD 154.34%
CLVT Average Price Target Wall Street Target
14.3 USD 231.41%
CLVT Highest Price Target Wall Street Target
20 USD 362.43%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088664422Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Clarivate Plc
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.26 M USD 1
9-12 MONTHS
119 K USD 1
Bought
0 USD 0
0-3 MONTHS
1.54 M USD 4
3-6 MONTHS
17.9 M USD 1
6-9 MONTHS
1.64 M USD 1
9-12 MONTHS
7. News
Clarivate Partners with CRKN to Further Canada's Research Goals Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions LONDON , June 3, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN), a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members. prnewswire.com - 2 weeks ago
Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026 LONDON , June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, announced today that it has successfully completed an incremental upsize of its term loan B credit facility. Pursuant to an amendment to the Company's existing credit agreement dated as of October 31, 2019, the Company incurred a new $500 million tranche of incremental term loans maturing in 2031, with an interest rate margin of 325 basis points per annum in the case of loans bearing interest by reference to term SOFR. prnewswire.com - 2 weeks ago
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON , June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions. prnewswire.com - 2 weeks ago
Clarivate Launches AI-based RiskMark to Accelerate Trademark Conflict Assessments New AI-based solution empowers trademark professionals to evaluate trademark risk and generate evidence-backed arguments with speed, ease, and confidence LONDON , May 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of RiskMark, an AI-powered solution combining global CompuMark trademark data and Darts-ip litigation data to evaluate trademark risk. Leveraging 172.5 million trademark records spanning 188 jurisdictions and over 5 million global court and administrative records, RiskMark combines generative and predictive AI to transform the process of assessing similarity risk based on relevant evidence. prnewswire.com - 4 weeks ago
Clarivate Report Reveals Top Trademark Portfolios Procter & Gamble, Nestlé, Apple, L'Oréal, Novartis, LG Electronics and Unilever among the largest portfolio owners in most registers LONDON , May 15, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Trademark filing trends 2025 report, analyzing ten key trademark registers worldwide: the United States (U.S.), Canada, the United Kingdom (U.K.), the European Union (EU), France, Germany, India, Mainland China, Japan, and Australia. The report reveals the top 20 largest local and foreign-based trademark portfolios in each region and the law firms managing the largest trademark portfolios. prnewswire.com - 1 month ago
Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development using new visual and data-driven insights LONDON , May 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection process. prnewswire.com - 1 month ago
Clarivate: Organic Growth Has Reached A Potential Inflection Point I rate Clarivate a buy, as 1Q25 marks a potential turning point with positive organic growth driven by stronger renewals and a healthier recurring revenue mix. CLVT's recurring revenue now makes up 83% of total sales, with organic recurring revenue growing by 0.6% y/y, indicating improved fundamentals. The IP segment shows promise, with 1.3% y/y organic growth, driven by stronger patent renewals and new AI tools like Derwent's AI-powered search feature. seekingalpha.com - 1 month ago
Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™ DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billion in 2025 and an impressive US$68.81 billion by 2030. The standardization of diverse datasets from sources such as clinical trials, electronic health records (EHRs), genomics, and real-world evidence is essential for the efficient exchange of information across various platforms and geographical regions. This standardization enhances multi-site clinical trials and cross-border research collaborations. Additionally, emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights. These technologies help simplify reports and create interactive dashboards. Furthermore, the increasing adoption of analytics in pre-clinical trials, drug discovery, and clinical trials, particularly for applications such as patient recruitment and site identification, helps to reduce the workload for researchers and investigators. These factors contribute significantly to the growing adoption of analytics across the life sciences industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653 Browse in-depth TOC on "Life Science Analytics Market" 100 - Tables50 - Figures500 - Pages By Based on type, the life science analytics services market is categorized into two main types: managed services and professional services. In 2024, the managed services segment held the largest share of the life science analytics market. This significant share is largely due to the increasing demand for advanced insights, the need for cost-effective drug development, technological advancements in the industry, and the necessity for ongoing support in strategic decision-making. These factors make outsourcing analytics and consulting more attractive for life science companies. Leading companies in the field offer consulting services that leverage data and analytics to evaluate opportunities, design analytics strategies, and implement appropriate technology solutions. For instance, in May 2023, SAS Institute (US) partnered with HTEC (US) to deliver strategic analytics consulting services across various sectors, including life sciences and healthcare. By Based on applications, The life science analytics market is divided into several applications, including research & development, commercial analytics, regulatory compliance, manufacturing and supply chain optimization, and safety. In 2024, the research & development segment held the largest share of this market. This significant share is mainly due to its capacity to accelerate drug discovery, optimize clinical trials, and improve research accuracy through advanced data analysis and AI-driven insights. Additionally, factors such as increasing R&D expenditure in the pharmaceutical and biopharmaceutical sectors, a rise in patent expirations and declining drug pipelines, and a growing focus on personalized medicine and precision therapeutics are further driving growth in this segment. By geography, the life science analytics market is divided into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience significant growth, with a noticeable annual growth rate during the forecast period. Key factors driving the expansion of life science analytics solutions in this region include a gradual shift towards adopting advanced technologies such as automation, artificial intelligence (AI), and machine learning (ML). Additionally, rising investments are attracting new market players, and the presence of leading educational institutions and research centers in Asia Pacific is fostering scientific innovation and technological advancement. Furthermore, increased direct investments from pharmaceutical and biotechnology companies in Europe and North America are anticipated to boost the adoption of life science analytics solutions in Asia. Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653 Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US), Microsoft (US), MaxisIT (US), ExlService Holdings (US), Inovalon (US), CitiusTech (US), Saama (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot (US), Salesforce (US), Google LLC (US), Amazon Web Services, Inc. (US), Veeva Systems (US), Elsevier (Netherlands), and Komodo Health, Inc. (US) are the major players in this market. These companies mainly focus on strategies such as acquisitions, collaborations, partnerships, expansion, and product launches and updates to remain competitive and further increase their share in the market. ORACLE (US): Oracle (US) is a leading company in life science analytics worldwide. The company offers analytics software and services for various applications, including research & development, commercialization, and more. Oracle is committed to continuously updating its products to meet customer expectations. Additionally, the company invests in expanding its solutions through partnerships and collaborations, ensuring tailored solutions for its users. In March 2025, Oracle partnered with Huntsville Hospital Health System (US) to standardize its Oracle Health Foundation electronic health record system across all facilities. This collaboration aims to provide consistent, high-quality care and a unified experience for both patients and providers as they move between different locations. With a broad customer base and a significant geographic presence, Oracle is a critical player in various IT software, hardware, and service markets, including life science analytics. MERATIVE (US): Merative (US) is another leading player in the life science analytics market. The company offers a comprehensive suite of informatics products and services tailored for life science analytics. By leveraging advanced technologies such as AI and ML, Merative enhances the accuracy and efficiency of evidence analysis. Its strong brand recognition and extensive product portfolio have significantly contributed to its success. Merative serves various sectors, including life science systems, clinical trial sponsors, and the medical device manufacturing industry. Additionally, the company has established offices across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. SAS INSTITUTE INC. (US) SAS Institute Inc. (US) is a company that specializes in analytics software and services. It offers a wide range of solutions, including advanced analytics, business intelligence, cloud analytics, customer intelligence, data operations, data management, decision management, fraud and security intelligence, in-memory analytics, performance management, risk management, and supply chain management. These solutions enable organizations to access, manage, analyze, and report on data to support informed decision-making. SAS Institute serves various industries, including communications, education, financial services, government, health insurance, healthcare, hospitality, insurance, life sciences, manufacturing, media, oil and gas, retail, travel and transportation, and utilities. Through its Life Sciences industry segment, the company also provides specialized analytics solutions for the life sciences sector. By leveraging AI and analytics driven by fast and relevant data, SAS aims to propel innovation in health and life sciences. The company supports customers in 146 countries across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. More than 82,000 business, government, and university sites utilize SAS OnDemand for Academics. For more information, Inquire Now! Related Reports: Healthcare Analytics Market Healthcare BPO Market Healthcare IT Market Artificial Intelligence (AI) in Healthcare Market Healthcare Data Monetization Market Get access to the latest updates on Life Science Analytics Companies and Life Science Analytics Market Size About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected]Visit Our Website: https://www.marketsandmarkets.com/ Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg https://www.prnewswire.com - 1 month ago
Clarivate Plc (CLVT) Q1 2025 Earnings Call Transcript Clarivate Plc (NYSE:CLVT ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Matti Shem Tov - Chief Executive Officer Jonathan Collins - Chief Financial Officer Conference Call Participants Greg Parrish - Morgan Stanley David Paige - RBC Capital Markets Shlomo Rosenbaum - Stifel George Tong - Goldman Sachs Surinder Thind - Jefferies Operator Thank you for joining ladies and gentlemen. My name is Karen, I'll be your conference operator. seekingalpha.com - 1 month ago
Clarivate (CLVT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com - 1 month ago
Clarivate PLC (CLVT) Q1 Earnings and Revenues Surpass Estimates Clarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.14 per share a year ago. zacks.com - 1 month ago
Clarivate Reports First Quarter 2025 Results — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON , April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. prnewswire.com - 1 month ago
8. Profile Summary

Clarivate Plc CLVT

image
COUNTRY GB
INDUSTRY Information Technology Services
MARKET CAP $ 2.95 B
Dividend Yield 0.00%
Description Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Contact 70 St. Mary Axe, London, EC3A 8BE https://www.clarivate.com
IPO Date Oct. 29, 2018
Employees 12000
Officers Mr. Mark J. Donohue CPA Head of Investor Relations Ms. Tabita Andersson Senior Vice President of Communications & Brand Mr. Matitiahu Shem Tov Chief Executive Officer & Director Mr. Henry Levy President of Life Sciences & Healthcare Mr. John Doulamis Senior Vice President & General Counsel Mr. Michael Easton Senior Vice President of Finance & Chief Accounting Officer Mr. Gordon Samson President of Intellectual Property Mr. William E. Graff Executive Vice President & Chief Information Officer Mr. Bar Veinstein President of Academia & Government Mr. Jonathan M. Collins Executive Vice President & Chief Financial Officer